Viewing Study NCT04591002


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2025-12-26 @ 2:23 AM
Study NCT ID: NCT04591002
Status: RECRUITING
Last Update Posted: 2025-06-26
First Post: 2020-09-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)
Sponsor: Samsung Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module